WBCIL at CPHI Milan 2026 | Liposomal Ingredient Supplier
Lipoedge™ Liposomal API Portfolio at CPHI Milan 2026:
- Lipoedge™ Liposomal Iron (patented)
- Lipoedge™ Liposomal Magnesium
- Lipoedge™ Liposomal Zinc
- Lipoedge™ Liposomal Glutathione
- Lipoedge™ Liposomal Vitamin C
- Lipoedge™ Liposomal Calcium
- Lipoedge™ Liposomal Alpha Lipoic Acid (ALA)
- Lipoedge™ Liposomal Vitamin D3
- Lipoedge™ Liposomal CoQ10
- Lipoedge™ Liposomal Vitamin K2
Pharmaceutical Ingredients at CPHI Milan 2026
Injectable-Grade Iron APIs
Injectable iron therapies are a growing segment of hospital and clinical procurement across Europe. Formulators and CDMO partners sourcing these APIs require strict adherence to parenteral-grade specifications. WBCIL manufactures the following injectable iron compounds with full technical and regulatory support:
Ferric Carboxymaltose
Ferric Carboxymaltose is a polynuclear iron (III)-hydroxide carboxymaltose complex. It is administered intravenously for iron deficiency anaemia in adults. It allows high single-dose iron repletion without the risk of dextran-related hypersensitivity. It is among the most widely prescribed injectable iron compounds in European clinical practice.
Ferric Derisomaltose
Ferric Derisomaltose is an iron–isomaltoside complex with a linear carbohydrate ligand. It supports high-dose single infusion with a low risk of hypophosphataemia — a documented concern with some competing parenteral iron formulations. It carries a well-characterised European regulatory profile.
Iron III Hydroxide Polymaltose Complex
Iron III Hydroxide Polymaltose Complex is a non-ionic macromolecular complex. It is used in both oral and injectable formulations. The polymaltose carbohydrate shell provides controlled, sustained iron release.
Oral Iron APIs
Ferrous Bisglycinate
Ferrous Bisglycinate is a chelated iron form with two glycine molecules coordinated to the ferrous ion. This chelate structure remains intact through gastric transit. Absorption occurs via peptide transporters, independent of the standard DMT-1 pathway. GI tolerability is significantly better than inorganic iron salts.
Chelated Minerals
Magnesium Bisglycinate
Magnesium Bisglycinate is a fully reacted amino acid chelate. Elemental magnesium content is high relative to molecular weight. It does not dissociate readily in the GI tract. European supplement brands specify it in sleep, stress, and muscle function formulations.
Zinc Bisglycinate
Zinc Bisglycinate is a glycinate chelate with documented absorption advantages over zinc sulphate and zinc oxide. It is specified in immunity, skin health, and reproductive health formulations. GI tolerability is a key selection driver over inorganic zinc salts.
Mineral Salts
Calcium Gluconate
Calcium Gluconate is a pharmaceutical-grade calcium salt with established use in both oral and injectable formulations. WBCIL manufactures injectable-grade Calcium Gluconate with specifications appropriate for parenteral use. It is used to treat hypocalcaemia, support cardiac function, and as an oral supplement.
Sodium Butyrate
Sodium Butyrate is the sodium salt of butyric acid, a short-chain fatty acid produced endogenously by colonic fermentation of dietary fibre. Exogenous Sodium Butyrate supplementation supports colonocyte function, gut barrier integrity, and microbiome health. It is increasingly specified in gastrointestinal health formulations across European markets.
Why WBCIL at CPHI Milan 2026?
CPHI Worldwide concentrates the global pharmaceutical ingredient market into three days. Procurement decisions that follow a CPHI meeting take weeks, not months. The quality of documentation a supplier brings to that meeting determines whether a qualification process starts. WBCIL brings the following to every conversation at CPHI Milan 2026:
- WHO-GMP certification across both manufacturing sites
- CEP and DMF documentation for key product lines
- Stability data and technical dossiers on request
- Regulatory support for EU, US, and emerging market submissions
- A liposomal technology platform with a granted patent on Liposomal Iron
European buyers sourcing from Indian pharmaceutical ingredient manufacturers apply exacting standards. WBCIL has supplied this market for years and understands those standards precisely.
CPhI Milan 2026 is where supply relationships at the European level are initiated and advanced. Our team will be present for the full duration of the event. Bring your sourcing requirements or technical brief to our stand. Documentation is available on-site and on request.
To pre-schedule a meeting at CPhI Milan 2026, write to us at wbcil@wbcil.com
